Regeneron Pharmaceuticals (REGN) Adjusts Course Amid Mixed Results in Melanoma Drug Trials
finance.yahoo.com
27.08.2026 14:43
4 views
Related stories
Salesforce Soars 14% as Claudeforce and a Guidance Raise End the Slump, ServiceNow Climbs 5%, Adobe Advances 3%
finance.yahoo.com · 27.08
The Kohl’s Recesson
finance.yahoo.com · 27.08
Futu ( FUTU) Posts Record Quarter Despite Regulatory Headwinds
finance.yahoo.com · 27.08
Hormel Foods narrows sales forecast
finance.yahoo.com · 27.08
Forget Bloom Energy Stock at $207 Per Share. Buy This Hydrogen-Focused ETF Instead for Just $43.
finance.yahoo.com · 27.08
Cybersecurity Stocks Rally on Twin Earnings Beats: Okta Spikes 22%, CrowdStrike Jumps 13%
finance.yahoo.com · 27.08